• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
TLX

TELIX PHARMACEUTICALS LIMITED - Corporate Spotlight

2.05% ! $14.90
Market Cap $5.042B  !
Healthcare Biotechnology
Add to My Watchlist

Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on... Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.More

No Corporate Spotlight currently available.

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$14.90 		Change
0.300(2.05%) 		Mkt cap ! $5.042B
Open High Low Value Volume
$14.50 $14.90 $14.31 $41.16M 2.800M

Buyers (Bids)

No. Vol. Price($)
1 862 $14.89
 

Sellers (Offers)

Price($) Vol. No.
$14.90 11564 1
View Market Depth
Last trade - 16.10pm 01/09/2025 (20 minute delay) ?
TLX (ASX) Chart

Top Stories

Another day, another FDA approval: 4D Medical pops +30% on keystone reg tick

4D Medical (ASX:4DX) shares soared over +30% intraday as the company’s the latest biotech to come to the market with news of an FDA approval @ for a biotech stock, the same thing as hitting bonanza gold grades.Listen to the HotCopper podcast for in-depth discussions and insights o...
Market Close: Wall Street's shut Monday night; slow week depends on US mood Good Afternoon and welcome to Market Close for Monday 1st September, I’m Jon Davidson. Spring is finally upon us and so too is a widely anticipated breather for markets both at home and abroad after smashing record after record throughout the year. Makes sense seeing as we&CloseCu...
Listen: HotCopper Wire Podcast 022 – Qatar royals bet on Invictus Energy In this HotCopper Wire episode, we look at Twiggy's latest Fortescue x Green Hydrogen claims and break down the Invictus-Qatar team-up.
HotCopper Highlights: Invcitus's surprise comeback story; EOS, Nanoveu & more Good Afternoon and welcome to HotCopper Highlights for Week 35 of the year, I’m Jon Davidson. These are the stocks you were watching and discussing most this week, starting with the most viewed. Invictus Energy was by far the most viewed and most discussed stock this week as the c...
Week 35 Wrap: If Invictus is above 15c again, the ASX is back baby. Even under 9,000pts By and large, the big story this week that captured HotCopper users’ attention, and that of local market punters everywhere, was the astonishing comeback of Invictus Energy. Invictus has spent years in the doldrums, driven largely by shareholder impatience in the stock, which it f...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.